BioCorRx (BICX) News Today $0.36 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Concentra Group Holdings Parent (NYSE:CON) & BioCorRx (OTCMKTS:BICX) Critical ContrastNovember 17, 2024 | americanbankingnews.comCritical Analysis: Concentra Group Holdings Parent (NYSE:CON) and BioCorRx (OTCMKTS:BICX)November 13, 2024 | americanbankingnews.comBioCorRx (OTCMKTS:BICX) vs. Concentra Group Holdings Parent (NYSE:CON) Head-To-Head ComparisonNovember 12, 2024 | americanbankingnews.comLa Rosa Holdings Corp. secures new financing, reshuffles leadershipOctober 6, 2024 | investing.comBioCorRx Inc: BioCorRx Reports Business Update for the Second Quarter of 2024August 16, 2024 | finanznachrichten.deBioCorRx Reports Business Update for the Second Quarter of 2024August 15, 2024 | globenewswire.comBioCorRx Reports Business Update for the First Quarter of 2024May 16, 2024 | finance.yahoo.comBioCorRx Inc. (BICX)April 18, 2024 | finance.yahoo.comBioCorRx receives new patent for novel compound to treat pain, depression, and schizophreniaApril 3, 2024 | seekingalpha.comBioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and SchizophreniaApril 3, 2024 | globenewswire.comBioCorRx Reports Business Update for 2023April 2, 2024 | globenewswire.comHow to Win a Business Grant: 4 Entrepreneurs Share Their TipsFebruary 29, 2024 | msn.comBioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUDFebruary 28, 2024 | globenewswire.comBIOCORRX INC NEW by BioCorRx Inc. Stock (OTC:BICX), Quotes and News SummaryFebruary 22, 2024 | benzinga.comBioCorRx Inc. (BICX) stock price, news, quote & history – Yahoo FinanceFebruary 13, 2024 | nz.finance.yahoo.comBioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of DirectorsFebruary 8, 2024 | finance.yahoo.comCollective Audience And 3 Other Stocks Under $1 Insiders Are BuyingJanuary 18, 2024 | msn.comBioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as PresidentJanuary 9, 2024 | finance.yahoo.comTAYNX Transamerica High Yield ESG-Class R4January 4, 2024 | seekingalpha.comCheng Fwa Industrial Ltd (5426)January 3, 2024 | investing.comBioCorRx Inc: BioCorRx Reports Business Update for the Third Quarter of 2023November 16, 2023 | finanznachrichten.deBioCorRx Reports Business Update for the Third Quarter of 2023November 14, 2023 | finance.yahoo.comBioCorRx President Awarded $14K Worth of Stock OptionsOctober 3, 2023 | benzinga.comBioCorRx Inc: BioCorRx Reports Business Update for the Second Quarter of 2023August 21, 2023 | finanznachrichten.deBioCorRx Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Naltrexone Pellet for Treatment of Opioid Use DisorderAugust 15, 2023 | finance.yahoo.comBioCorRx Reports Business Update for the Second Quarter of 2023August 14, 2023 | finance.yahoo.comTokai Holdings Corp (3167)July 29, 2023 | investing.comFukui Bank Ltd (8362)July 29, 2023 | investing.comNissha Printing Co Ltd (7915)July 28, 2023 | investing.comDSC Investment Inc (241520)July 18, 2023 | investing.comBioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use DisorderJuly 18, 2023 | finance.yahoo.comBioCorRx Inc: BioCorRx Provides Business Update for the First Quarter of 2023May 16, 2023 | finanznachrichten.deBioCorRx Provides Business Update for the First Quarter of 2023May 16, 2023 | finance.yahoo.comBioCorRx Provides Business Update for 2022April 3, 2023 | finance.yahoo.comBioCorRx Announced Interim Positive Safety and Pharmacokinetic Results of Phase 1 Clinical Trial at 4th Annual NIH HEAL Initiative Investigator MeetingMarch 7, 2023 | finance.yahoo.comBioCorRx to Present at Sequire Biotechnology Conference on February 2ndJanuary 27, 2023 | finance.yahoo.comBioCorRx Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use DisorderJanuary 19, 2023 | finance.yahoo.comBioCorRx Partners with Government Plus to Expand its Beat Addiction Recovery Program in the United StatesDecember 7, 2022 | finance.yahoo.comBioCorRx Board of Directors Approves Exploration of Potential Spin-Off of BioCorRx Pharmaceuticals, Inc.November 22, 2022 | finance.yahoo.comBioCorRx Inc: BioCorRx Provides Business Update for the Third Quarter of 2022November 15, 2022 | finanznachrichten.deBioCorRx Provides Business Update for the Third Quarter of 2022November 15, 2022 | finance.yahoo.comBioCorRx to Present at the LD Micro Main Event XV on October 25thOctober 24, 2022 | finance.yahoo.comBioCorRx to Participate at the LD Micro Main Event XVOctober 20, 2022 | finance.yahoo.comBioCorRx Completes Final Subject Enrollment in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use DisorderOctober 13, 2022 | finance.yahoo.com2B3D Shares Addiction Treatment Deliverables from BioCorRx for Phase I of Mental Health Metaverse Platform BetaSeptember 29, 2022 | nz.finance.yahoo.comBICX: Pivotal trial underwaySeptember 16, 2022 | finance.yahoo.comBioCorRx to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceSeptember 6, 2022 | apnews.comBICX.PK - Biocorrx Inc | Stock Price & Latest News | ReutersSeptember 4, 2022 | reuters.comBioCorRx Provides Business Update for the Second Quarter of 2022August 16, 2022 | finance.yahoo.comBioCorRx to Participate in the Benzinga All Access Event on July 15thJuly 13, 2022 | finance.yahoo.com Get BioCorRx News Delivered to You Automatically Sign up to receive the latest news and ratings for BICX and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. BICX Media Mentions By Week BICX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BICX News Sentiment▼-0.360.47▲Average Medical News Sentiment BICX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BICX Articles This Week▼10▲BICX Articles Average Week Get BioCorRx News Delivered to You Automatically Sign up to receive the latest news and ratings for BICX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OPGN News Today PMD News Today TOI News Today BRTX News Today OTRK News Today ATIP News Today MGRX News Today ATPC News Today KDLY News Today UDHI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BICX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCorRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCorRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
